Universität zu Köln

Zeriouh, Mohamed, Mohite, Prashant ORCID: 0000-0001-5533-3089, Rai, Binu, Sabashnikov, Anton ORCID: 0000-0002-6289-1035, Fatullayev, Javid, Saez, Diana Garcia, Zych, Bartrlomiej, Ghodsizad, Ali, Rahmanian, Parwis, Choi, Yeong-Hoon, Wahlers, Thorsten, Simon, Andre R., Popov, Aron F. and Koch, Achim (2016). Short-term ventricular assist device as a bridge to decision in cardiogenic shock: is it a justified strategy? Int. J. Artif. Organs, 39 (3). S. 114 - 121. LONDON: SAGE PUBLICATIONS LTD. ISSN 1724-6040

Full text not available from this repository.

Abstract

Purpose: Low cardiac output syndrome is associated with significant mortality. In patients with refractory low cardiac output left ventricular assist devices (VAD) are used to re-establish cardiac output and to prevent death. However, long-term LVAD implantation in these is complicated by a high rate of right heart failure and mortality. Therefore, our strategy is to implant a short-term VAD (left or biventricular) as a bridge to decission. Methods: We retrospectively analysed data from 66 patients who received a short-term LVAD support prior to implantation of a long-term LVAD or HTx between 2003 and 2014. We performed short-term LVAD (CentriMag; Thoratec) implantation via median sternotomy with percutaneous cannulas. Patients were included regardless of perioperative status and severity of heart failure. Patients suffering postcardiotomy cardiogenic shock, receiving isolated RVAD as well as posttransplant patients were excluded from this study. Results: Mean duration of support in the survivor group was 35 +/- 25 days versus 25 +/- 25 days in the nonsurvivor group (n.s.), range from 1 to 109 days. The overall survival on support was 40 (60%) patients. In the survivor group 12 patients could be successfully weaned from the system, 12 patients received a heart transplant and in 16 a long-term VAD was implanted. In the nonsurvivor group the rate of preoperative extracorporeal life support, the rate of postoperative renal failure and multiorgan failure was significantly higher. Conclusions: Thanks to its capacity for full ventricular support, short-term univentricular or biventricular LevotronixCentriMag VAD currently represents an ideal solution for bridge-to-decision.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Zeriouh, Mohamed UNSPECIFIED UNSPECIFIED UNSPECIFIED Mohite, Prashant UNSPECIFIED orcid.org/0000-0001-5533-3089 UNSPECIFIED Rai, Binu UNSPECIFIED UNSPECIFIED UNSPECIFIED Sabashnikov, Anton UNSPECIFIED orcid.org/0000-0002-6289-1035 UNSPECIFIED Fatullayev, Javid UNSPECIFIED UNSPECIFIED UNSPECIFIED Saez, Diana Garcia UNSPECIFIED UNSPECIFIED UNSPECIFIED Zych, Bartrlomiej UNSPECIFIED UNSPECIFIED UNSPECIFIED Ghodsizad, Ali UNSPECIFIED UNSPECIFIED UNSPECIFIED Rahmanian, Parwis UNSPECIFIED UNSPECIFIED UNSPECIFIED Choi, Yeong-Hoon UNSPECIFIED UNSPECIFIED UNSPECIFIED Wahlers, Thorsten UNSPECIFIED UNSPECIFIED UNSPECIFIED Simon, Andre R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Popov, Aron F. UNSPECIFIED UNSPECIFIED UNSPECIFIED Koch, Achim UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-281903
DOI:	10.5301/ijao.5000488
Journal or Publication Title:	Int. J. Artif. Organs
Volume:	39
Number:	3
Page Range:	S. 114 - 121
Date:	2016
Publisher:	SAGE PUBLICATIONS LTD
Place of Publication:	LONDON
ISSN:	1724-6040
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language EXTRACORPOREAL LIFE-SUPPORT; CENTRIMAG; OUTCOMES; SYSTEM; IMPLANTATION; EXPERIENCE Multiple languages Engineering, Biomedical; Transplantation Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/28190